2012 ANNUAL MEETING HIGHLIGHTS Advanced Prostate Cancer Course #49IC
Advanced Prostate Cancer 2012: Understanding and Sequencing the Plethora of New Agents
Androgen Deprivation Therapy and the Treatment of Advanced Prostate Cancer
Management of Castration Resistant Prostate Cancer
Our patients’ lives.
State-of-the-Art Lecture: Osteoporosis and Bone Health in Elderly Men Receiving Androgen Ablation Panel Discussion: Systemic Treatments for Castrate Resistant Prostate—In What Sequence? Take Home Message: Advanced Prostate Cancer
Abstract Highlights AUANews Editor
AUA 2012 ANNUAL MEETING HIGHLIGHTS
Advanced Prostate Cancer
Gopal H. Badlani, MD
American Urological Association 1000 Corporate Boulevard Linthicum, MD 21090 Copyright © 2012 by American Urological Association None of the contents may be reproduced in any form without prior written permission of the publisher. The opinions expressed in this publication are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the American Urological Association or any other persons. Some articles in this publication may discuss unapproved or “off-label” uses of products. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this publication should not be used by clinicians without evaluation of their patients’ conditions and of possible contraindications or dangers in use, review of any applicable manufacturers’ product information and comparison with the recommendations of the authorities.
This CME activity is supported by educational grants from Amgen, Inc., Astellas Scientific and Medical Affairs, Inc., Janssen Biotech, Inc., Medivation, Inc. and Millennium: The Takeda Oncology Company.